Publication | Closed Access

Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial

Hiv-1 AcquisitionTreatment And PreventionHuman RetrovirusImmunologyClinical TrialsAntiviral Drug DevelopmentAntiviral TherapyPharmacotherapyAntiviral DrugHivMedicinePre-exposure Prophylaxis